Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Honz Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of pediatric medicines. The company offers a broad portfolio of products, including traditional Chinese medicines and chemical drugs, targeting respiratory, digestive, and anti-infective indications in children. Known for its "Huluwa" brand, it operates several GMP-certified manufacturing facilities and maintains a strong presence in the domestic Chinese market. Honz is committed to pediatric health and has established itself as a key player in the specialized field of children's medicine in China. The company is listed on the Shanghai Stock Exchange and continues to expand its R&D pipeline to address unmet needs in pediatric care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Honz Pharmaceutical.